Published in Int J Chron Obstruct Pulmon Dis on April 15, 2009
The AIMAR recommendations for early diagnosis of chronic obstructive respiratory disease based on the WHO/GARD model*. Multidiscip Respir Med (2014) 0.97
Use of the Breathlessness, Cough, and Sputum Scale (BCSS(©)) in Pulmonary Rehabilitation. Open Respir Med J (2013) 0.87
Engaging community stakeholders to evaluate the design, usability, and acceptability of a chronic obstructive pulmonary disease social media resource center. JMIR Res Protoc (2015) 0.82
The impact of a proactive chronic care management program on hospital admission rates in a German health insurance society. Popul Health Manag (2010) 0.82
Influencing the decline of lung function in COPD: use of pharmacotherapy. Int J Chron Obstruct Pulmon Dis (2010) 0.82
Strategies to improve anxiety and depression in patients with COPD: a mental health perspective. Neuropsychiatr Dis Treat (2016) 0.78
Efficacy of a self-management plan in exacerbations for patients with advanced COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future. Multidiscip Respir Med (2010) 0.75
Chronic disease self-management program: 2-year health status and health care utilization outcomes. Med Care (2001) 8.95
Reduction of hospital utilization in patients with chronic obstructive pulmonary disease: a disease-specific self-management intervention. Arch Intern Med (2003) 6.82
Effectiveness of interventions to improve patient compliance: a meta-analysis. Med Care (1998) 5.76
Pulmonary Rehabilitation: Joint ACCP/AACVPR Evidence-Based Clinical Practice Guidelines. Chest (2007) 5.01
Self-management education for patients with chronic obstructive pulmonary disease. Cochrane Database Syst Rev (2007) 3.74
Results at 1 year of outpatient multidisciplinary pulmonary rehabilitation: a randomised controlled trial. Lancet (2000) 3.68
A controlled trial of two forms of self-management education for adults with asthma. Am J Med (1993) 3.17
Does disease management improve clinical and economic outcomes in patients with chronic diseases? A systematic review. Am J Med (2004) 2.64
Effects of pulmonary rehabilitation on physiologic and psychosocial outcomes in patients with chronic obstructive pulmonary disease. Ann Intern Med (1995) 2.64
Treating COPD--the TORCH trial, P values, and the Dodo. N Engl J Med (2007) 2.26
Ecological approaches to self-management: the case of diabetes. Am J Public Health (2005) 2.23
Risk of depression in patients with chronic obstructive pulmonary disease and its determinants. Thorax (2002) 2.09
Quality of life and its predictors in patients with mild hypoxemia and chronic obstructive pulmonary disease. Arch Intern Med (1984) 2.07
Systematic review of the chronic care model in chronic obstructive pulmonary disease prevention and management. Arch Intern Med (2007) 2.06
A nurse led intermediate care package in patients who have been hospitalised with an acute exacerbation of chronic obstructive pulmonary disease. Thorax (2007) 1.89
Effectiveness of chronic obstructive pulmonary disease-management programs: systematic review and meta-analysis. Am J Med (2008) 1.76
Anxiety and depression in patients with chronic obstructive pulmonary disease (COPD). A review. Nord J Psychiatry (2004) 1.73
Treatment of dyspnea in COPD. A controlled clinical trial of dyspnea management strategies. Chest (1995) 1.70
A model of self-regulation for control of chronic disease. Health Educ Behav (2001) 1.64
Psychological and cognitive outcomes of a randomized trial of exercise among patients with chronic obstructive pulmonary disease. Health Psychol (1998) 1.63
Symptom experience and quality of life of women following breast cancer treatment. J Womens Health (Larchmt) (2007) 1.58
Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med (2003) 1.56
Effects of a comprehensive school-based asthma program on symptoms, parent management, grades, and absenteeism. Chest (2004) 1.56
Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients. Eur Respir J (2003) 1.49
Patient-centred outcomes in primary care management of COPD - what do recent clinical trial data tell us? Prim Care Respir J (2004) 1.44
Self-management reduces both short- and long-term hospitalisation in COPD. Eur Respir J (2005) 1.40
Effects of a comprehensive self-management programme in patients with chronic obstructive pulmonary disease. Eur Respir J (2003) 1.29
A chronic disease management programme can reduce days in hospital for patients with chronic obstructive pulmonary disease. Intern Med J (2004) 1.28
Social science and health research: growth at the National Institutes of Health. Am J Public Health (2004) 1.27
Economic benefits of self-management education in COPD. Chest (2006) 1.25
Comprehensive pulmonary rehabilitation for anxiety and depression in adults with chronic obstructive pulmonary disease: Systematic review and meta-analysis. J Psychosom Res (2007) 1.21
A randomized trial of a self-regulation intervention for women with asthma. Chest (2007) 1.20
Evaluation of a self-management plan for chronic obstructive pulmonary disease. Eur Respir J (1997) 1.18
Impact of pulmonary rehabilitation on psychosocial morbidity in patients with severe COPD. Chest (2006) 1.16
Home-based exercise is capable of preserving hospital-based improvements in severe chronic obstructive pulmonary disease. Respir Med (2000) 1.15
Impact of patient education and self-management on morbidity in asthmatics and patients with chronic obstructive pulmonary disease. Respir Med (2000) 1.14
Inspiratory muscle training compared with other rehabilitation interventions in chronic obstructive pulmonary disease: a systematic review update. J Cardiopulm Rehabil Prev (2008) 1.10
Randomised controlled trial of home based care of patients with chronic obstructive pulmonary disease. BMJ (2002) 1.10
Quality of life in elderly patients with COPD: measurement and predictive factors. Respir Med (1998) 1.07
Systematic review of the effects of chronic disease management on quality-of-life in people with chronic obstructive pulmonary disease. Respir Med (2007) 1.07
A social cognitive view of self-regulated learning about health. Health Educ Behav (2014) 1.06
Factors affecting health status in COPD patients with co-morbid anxiety or depression. Int J Chron Obstruct Pulmon Dis (2007) 1.05
Psychological changes during a controlled trial of rehabilitation in chronic respiratory disability. Thorax (1982) 1.04
A randomized control trial of nursing-based case management for patients with chronic obstructive pulmonary disease. Lippincotts Case Manag (2002) 1.00
Behavioural effect of self-treatment guidelines in a self-management program for adults with asthma. Patient Educ Couns (2001) 0.97
Managing chronic obstructive pulmonary disease in the community. A randomized controlled trial of home-based pulmonary rehabilitation for elderly housebound patients. J Cardiopulm Rehabil (2005) 0.97
The effects of patient education in COPD in a 1-year follow-up randomised, controlled trial. Patient Educ Couns (2004) 0.97
Evaluation of an education program for elementary school children with asthma. J Asthma (2003) 0.97
Effect of acupuncture or acupressure on quality of life of patients with chronic obstructive asthma: a pilot study. J Altern Complement Med (2003) 0.93
Gender moderates the effects of exercise therapy on health-related quality of life among COPD patients. Chest (2001) 0.92
Effects of treatment on two types of self-efficacy in people with chronic obstructive pulmonary disease. J Pain Symptom Manage (2006) 0.91
The most effective psychologically-based treatments to reduce anxiety and panic in patients with chronic obstructive pulmonary disease (COPD): a systematic review. Patient Educ Couns (2002) 0.91
How are you doing? What are you doing? Differing perspectives in the assessment of individuals with COPD. COPD (2007) 0.91
Anxiety and self-management behaviour in chronic obstructive pulmonary disease: what has been learned? Chron Respir Dis (2004) 0.85
Meta-analysis of the effects of psychoeducational care in adults with chronic obstructive pulmonary disease. Patient Educ Couns (1996) 0.84
The effects of education alone and in combination with pulmonary rehabilitation on self-efficacy in patients with COPD. Rehabil Nurs (1998) 0.83
Pulmonary rehabilitation compared with brief advice given for severe chronic obstructive pulmonary disease. J Cardiopulm Rehabil (2002) 0.81
Use of a chronic disease management programme in COPD to reduce hospital admissions. Chron Respir Dis (2006) 0.80
Heart disease management by women: does intervention format matter? Health Educ Behav (2007) 0.78
The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding. Am J Med (2006) 0.78
Dyspnea self-management in patients with chronic obstructive pulmonary disease: moderating effects of depressed mood. Psychosomatics (2005) 0.78
Heart disease management by women: does intervention format matter? Health Educ Behav (2014) 0.76
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med (2012) 22.96
An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med (2011) 22.39
An official American Thoracic Society/European Respiratory Society statement: asthma control and exacerbations: standardizing endpoints for clinical asthma trials and clinical practice. Am J Respir Crit Care Med (2009) 9.38
Azithromycin for prevention of exacerbations of COPD. N Engl J Med (2011) 8.66
An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med (2013) 6.82
Acute exacerbations of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2007) 6.71
Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med (2012) 6.51
An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline: Treatment of Idiopathic Pulmonary Fibrosis. An Update of the 2011 Clinical Practice Guideline. Am J Respir Crit Care Med (2015) 6.03
Pulmonary arterial enlargement and acute exacerbations of COPD. N Engl J Med (2012) 5.54
Idiopathic pulmonary fibrosis: clinically meaningful primary endpoints in phase 3 clinical trials. Am J Respir Crit Care Med (2012) 5.33
International guidelines for the selection of lung transplant candidates: 2006 update--a consensus report from the Pulmonary Scientific Council of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant (2006) 4.95
Analysis of the lung microbiome in the "healthy" smoker and in COPD. PLoS One (2011) 4.65
Roflumilast in moderate-to-severe chronic obstructive pulmonary disease treated with longacting bronchodilators: two randomised clinical trials. Lancet (2009) 4.40
Mechanisms of pulmonary fibrosis. Annu Rev Med (2004) 4.37
Roflumilast in symptomatic chronic obstructive pulmonary disease: two randomised clinical trials. Lancet (2009) 4.29
Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med (2010) 4.19
NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury. Nat Med (2009) 4.05
A Randomized Trial of Long-Term Oxygen for COPD with Moderate Desaturation. N Engl J Med (2016) 3.99
GOLD 2011 disease severity classification in COPDGene: a prospective cohort study. Lancet Respir Med (2012) 3.98
Idiopathic nonspecific interstitial pneumonia: report of an American Thoracic Society project. Am J Respir Crit Care Med (2008) 3.97
Simvastatin for the prevention of exacerbations in moderate-to-severe COPD. N Engl J Med (2014) 3.51
Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology (2011) 3.30
Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol (2010) 3.12
Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med (2004) 2.97
Computed tomography-based biomarker provides unique signature for diagnosis of COPD phenotypes and disease progression. Nat Med (2012) 2.95
Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med (2005) 2.86
Gender and chronic obstructive pulmonary disease: why it matters. Am J Respir Crit Care Med (2007) 2.80
Can a disease self-management program reduce health care costs? The case of older women with heart disease. Med Care (2003) 2.78
Spirometry utilization for COPD: how do we measure up? Chest (2007) 2.77
Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.71
Acellular normal and fibrotic human lung matrices as a culture system for in vitro investigation. Am J Respir Crit Care Med (2012) 2.65
Long-term follow-up of patients receiving lung-volume-reduction surgery versus medical therapy for severe emphysema by the National Emphysema Treatment Trial Research Group. Ann Thorac Surg (2006) 2.53
Idiopathic pulmonary fibrosis: prognostic value of changes in physiology and six-minute-walk test. Am J Respir Crit Care Med (2006) 2.37
Fibroblastic foci in usual interstitial pneumonia: idiopathic versus collagen vascular disease. Am J Respir Crit Care Med (2003) 2.35
Clinical predictors of a diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med (2010) 2.20
Exacerbations of chronic obstructive pulmonary disease. Proc Am Thorac Soc (2007) 2.19
Relationship between quantitative CT metrics and health status and BODE in chronic obstructive pulmonary disease. Thorax (2012) 2.15
Prognostic value of desaturation during a 6-minute walk test in idiopathic interstitial pneumonia. Am J Respir Crit Care Med (2003) 2.10
Hydrogen peroxide is a diffusible paracrine signal for the induction of epithelial cell death by activated myofibroblasts. FASEB J (2005) 2.09
Self-management programmes for COPD: moving forward. Chron Respir Dis (2012) 2.07
Idiopathic pulmonary fibrosis: pathogenesis and therapeutic approaches. Drugs (2004) 2.05
Survival after lung volume reduction in chronic obstructive pulmonary disease: insights from small airway pathology. Am J Respir Crit Care Med (2007) 2.04
Design of the Subpopulations and Intermediate Outcomes in COPD Study (SPIROMICS). Thorax (2013) 1.99
Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community-acquired pneumonia. Clin Infect Dis (2002) 1.98
Genetic association analysis of functional impairment in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2006) 1.98
Significance of the microbiome in obstructive lung disease. Thorax (2012) 1.97
Genetic determinants of emphysema distribution in the national emphysema treatment trial. Am J Respir Crit Care Med (2007) 1.94
Idiopathic interstitial pneumonia: do community and academic physicians agree on diagnosis? Am J Respir Crit Care Med (2007) 1.94
Modulation of prosurvival signaling in fibroblasts by a protein kinase inhibitor protects against fibrotic tissue injury. Am J Pathol (2005) 1.93
An essential role for fibronectin extra type III domain A in pulmonary fibrosis. Am J Respir Crit Care Med (2007) 1.91
Lung dendritic cell expression of maturation molecules increases with worsening chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2009) 1.90
Evidence for tissue-resident mesenchymal stem cells in human adult lung from studies of transplanted allografts. J Clin Invest (2007) 1.87
A micro RNA processing defect in rapidly progressing idiopathic pulmonary fibrosis. PLoS One (2011) 1.87
Technology and its role in respiratory care. Prim Care Respir J (2009) 1.87
Patient understanding, detection, and experience of COPD exacerbations: an observational, interview-based study. Chest (2006) 1.84
CT metrics of airway disease and emphysema in severe COPD. Chest (2009) 1.81
Randomized trial of acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med (2014) 1.80
Diagnosis, assessment, and treatment of non-pulmonary arterial hypertension pulmonary hypertension. J Am Coll Cardiol (2009) 1.78
Sex, depression, and risk of hospitalization and mortality in chronic obstructive pulmonary disease. Arch Intern Med (2007) 1.77
Improvements in health care use associated with community coalitions: long-term results of the allies against asthma initiative. Am J Public Health (2013) 1.72
Recent advances in idiopathic pulmonary fibrosis. Chest (2007) 1.69
Predictors of chronic obstructive pulmonary disease exacerbation reduction in response to daily azithromycin therapy. Am J Respir Crit Care Med (2014) 1.68
Physician and patient perceptions in COPD: the COPD Resource Network Needs Assessment Survey. Am J Med (2005) 1.67
The National Emphysema Treatment Trial (NETT) Part II: Lessons learned about lung volume reduction surgery. Am J Respir Crit Care Med (2011) 1.64
Racial differences in quality of life in patients with COPD. Chest (2011) 1.64
An Official American Thoracic Society/European Respiratory Society Statement: Research questions in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2015) 1.63
Enhanced monocyte chemoattractant protein-3/CC chemokine ligand-7 in usual interstitial pneumonia. Am J Respir Crit Care Med (2004) 1.59
Mesenchymal stromal cells in bronchoalveolar lavage as predictors of bronchiolitis obliterans syndrome. Am J Respir Crit Care Med (2010) 1.58
Future directions in idiopathic pulmonary fibrosis research. An NHLBI workshop report. Am J Respir Crit Care Med (2014) 1.54
Reduction of exacerbations by the PDE4 inhibitor roflumilast--the importance of defining different subsets of patients with COPD. Respir Res (2011) 1.52
Pulmonary diseases and the heart. Circulation (2007) 1.52
Increased cytokine response of rhinovirus-infected airway epithelial cells in chronic obstructive pulmonary disease. Am J Respir Crit Care Med (2010) 1.51
Treatment of idiopathic pulmonary fibrosis with ambrisentan: a parallel, randomized trial. Ann Intern Med (2013) 1.51
Developing a pictorial Epworth Sleepiness Scale. Thorax (2010) 1.49
Periostin promotes fibrosis and predicts progression in patients with idiopathic pulmonary fibrosis. Am J Physiol Lung Cell Mol Physiol (2012) 1.44
Open-access biorepository for idiopathic pulmonary fibrosis. The way forward. Ann Am Thorac Soc (2014) 1.42
Clinical significance of radiologic characterizations in COPD. COPD (2009) 1.41
Pulmonary hypertension and computed tomography measurement of small pulmonary vessels in severe emphysema. Am J Respir Crit Care Med (2009) 1.36
Promoting recruitment of minority ethnic groups into research: qualitative study exploring the views of South Asian people with asthma. J Public Health (Oxf) (2011) 1.34
Predicting risk of airflow obstruction in primary care: Validation of the lung function questionnaire (LFQ). Respir Med (2010) 1.33
Delayed radionucleotide gastric emptying studies predict morbidity in diabetics with symptoms of gastroparesis. Gastroenterology (2009) 1.33
Implementing practice guidelines: a workshop on guidelines dissemination and implementation with a focus on asthma and COPD. Can Respir J (2006) 1.32
The role of choice in health education intervention trials: a review and case study. Soc Sci Med (2003) 1.30
Variable prostaglandin E2 resistance in fibroblasts from patients with usual interstitial pneumonia. Am J Respir Crit Care Med (2007) 1.29
Smoking-related interstitial lung disease: radiologic-clinical-pathologic correlation. Radiographics (2008) 1.27
Statins and pulmonary fibrosis: the potential role of NLRP3 inflammasome activation. Am J Respir Crit Care Med (2012) 1.27
Thoracic surgery in a crisis. BMJ (2002) 1.27
A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells. Mol Cell Neurosci (2013) 1.25
Predicting pulmonary fibrosis disease course from past trends in pulmonary function. Chest (2014) 1.25
Course of FEV(1) after onset of bronchiolitis obliterans syndrome in lung transplant recipients. Am J Respir Crit Care Med (2007) 1.24
Facilitating the recruitment of minority ethnic people into research: qualitative case study of South Asians and asthma. PLoS Med (2009) 1.24
Physical activity, health status and risk of hospitalization in patients with severe chronic obstructive pulmonary disease. Respiration (2010) 1.22
TLR9 differentiates rapidly from slowly progressing forms of idiopathic pulmonary fibrosis. Sci Transl Med (2010) 1.21
Human pulmonary fibroblasts exhibit altered interleukin-4 and interleukin-13 receptor subunit expression in idiopathic interstitial pneumonia. Am J Pathol (2004) 1.20
Cytotoxic potential of lung CD8(+) T cells increases with chronic obstructive pulmonary disease severity and with in vitro stimulation by IL-18 or IL-15. J Immunol (2010) 1.18
Do practices comply with key recommendations of the British Asthma Guideline? If not, why not? Prim Care Respir J (2007) 1.14
Physiologic variables and functional status independently predict COPD hospitalizations and emergency department visits in patients with severe COPD. COPD (2007) 1.12
How much of a primary care nurse's time is spent on those with respiratory disease? A pilot study. Prim Care Respir J (2007) 1.12
Obligatory role for interleukin-13 in obstructive lesion development in airway allografts. Am J Pathol (2006) 1.11